IGC PHARMA, INC. (IGC) Gross margin 2016–2025
IGC PHARMA, INC. (IGC) gross margin by fiscal year — reported gross profit divided by reported revenue.
48.7%FY2025 · since FY2016: 13.2% → 48.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 48.7% | -5.8 pp |
| FY2024 | 54.5% | +6.0 pp |
| FY2023 | 48.5% | -0.3 pp |
| FY2022 | 48.9% | +36.3 pp |
| FY2021 | 12.6% | +9.8 pp |
| FY2020 | 2.8% | +0.2 pp |
| FY2019 | 2.6% | -1.2 pp |
| FY2018 | 3.7% | -33.9 pp |
| FY2017 | 37.6% | +24.4 pp |
| FY2016 | 13.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice